Ignite Creation Date:
2025-12-25 @ 12:02 AM
Ignite Modification Date:
2026-03-04 @ 12:03 PM
Study NCT ID:
NCT01871558
Status:
COMPLETED
Last Update Posted:
2016-04-21
First Post:
2013-06-04
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Vildagliptin/Metformin in T2DM Patients Starting Basal Insulin
Sponsor:
Novartis Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CLAF237AFR07
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None